How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 801–900 of 1,008
NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP
Chen, Y., Zhang, Q.-S., Shao, Q.-H., Wang, S., Yuan, Y., Chen, N., & Wang, H. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0209-1 · Cited by 26
Huang, W., Xu, Y., Zhang, Y., Zhang, P., Zhang, Q., Zhang, Z., & Xu, F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14774 · Cited by 30
Molecular Targets Involved in the Neuroprotection Mediated by Terpenoids
González‐Cofrade, L., Heras, B. D. L., Ticona, L. A., & Palomino, O. M. (2019) · Planta Medica · doi:10.1055/a-0953-6738 · Cited by 28
Grebenik, E. A., Surin, A. M., Bardakova, K. N., Demina, T. S., Минаев, Н. В., Veryasova, N. N., Artyukhova, M. A., Krasilnikova, I. A., Бакаева, З. В., Sorokina, E. G., et al. (2019) · Biomedical Materials · doi:10.1088/1748-605x/ab6228 · Cited by 27
Fisher, E. S., Amarante, M. A., Lowry, N., Lotz, S., Farjood, F., Temple, S., Hill, C. E., & Kiehl, T. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02627-3 · Cited by 35
Kamrani-Sharif, R., Hayes, A. W., Gholami, M., Salehirad, M., Khani, M. A., Motaghinejad, M., & Emanuele, E. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102352 · Cited by 31
Artificial Intelligence in The Management of Neurodegenerative Disorders
Dhankhar, S., Mujwar, S., Garg, N., Chauhan, S., Saini, M., Sharma, P., Kumar, S., Sharma, S. K., Kamal, M. A., & Rani, N. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273266095231009092603 · Cited by 40
Fang, M., Zhou, Y., He, K., Lu, Y., Tao, F., & Huang, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04775-y · Cited by 36
“An increasing amount of data points to the impact of neuroinflammation on the intracerebral environment during the disease as a contributing factor to the development of neurodegeneration, while microglia is an important participant in causing neuroinflammation [28].”
Ni, C., Wang, L., Bai, Y., Huang, F., Shi, H., Wu, H., Wu, X., & Huang, J. L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.053 · Cited by 26
Alemán-Villa, K. M., Armienta-Rojas, D. A., Camberos-Barraza, J., Rábago-Monzón, Á. R., Camacho-Zamora, A., Osuna‐Ramos, J. F., Magaña‐Gómez, J. A., Guadrón‐Llanos, A. M., Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000548021 · Cited by 41
“Network-based approaches have identified critical regulators such as NF-κB, NLRP3 inflammasome components, and complement factors that orchestrate glial and peripheral immune activation [143].”
Lee, E.-J., Choi, M. J., Lee, G., Gaire, B. P., Choi, J. W., & Kim, H.-S. (2017) · Oncotarget · doi:10.18632/oncotarget.20207 · Cited by 27
“However, prolonged and unresolved inflammation give rise to destructive chronic inflammation that results in neuronal cell death and ultimately to the onset of neurodegenerative diseases [5-7].”
BackgroundPerego, J., Mendes, A. V., Bourbon, C., Camosseto, V., Combes, A. J., Liu, H., Manh, T. V., Dalet, A., Chasson, L., Spinelli, L., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aam8104 · Cited by 29
“advantage for the treatment of neurodegenerative diseases, which often feature increased neuronal cell death due to accumulation of misfolded proteins and acute inflammation that further triggers tissue damage and contributes to disease progression (20, 53).”
BackgroundDavies, C. L., Patir, A., & McColl, B. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01048 · Cited by 25
Arivazhagan, L., Ruiz, H. H., Wilson, R. A., Manigrasso, M. B., Gugger, P. F., Fisher, E. A. A., Moore, K. J., Ramasamy, R., & Schmidt, A. M. (2020) · Circulation Research · doi:10.1161/circresaha.120.315900 · Cited by 25
Lind, A., Boraxbekk, C., Petersen, E. T., Paulson, O. B., Andersen, O., Siebner, H. R., & Marsman, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15456 · Cited by 30
“This hypothesis is strengthened by neuroinflammation being a landmark of brain ageing with links to cognitive decline, dementia and neurodegenerative disease (Chen et al., 2016; Lupo et al., 2019; Lynch, 2010; Ransohoff, 2016).”
BackgroundScarpa, M., Molloy, C., Jenkins, L., Strellis, B., Budgett, R. F., Hesse, S., Dwomoh, L., Marsango, S., Tejeda, G. S., Rossi, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107389118 · Cited by 28
“Murine prion disease, similar to many human neurodegenerative diseases (27), is associated with profound neuroinflammation characterized by activation of both astrocytes and microglia (28).”
Cytosolic Self-DNA—A Potential Source of Chronic Inflammation in Aging
Akbari, M., Shanley, D. P., Bohr, V. A., & Rasmussen, L. J. (2021) · Cells · doi:10.3390/cells10123544 · Cited by 27
Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure
Elman, J. A., Puckett, O. K., Hagler, D. J., Pearce, R. C., Fennema‐Notestine, C., Hatton, S. N., Lyons, M. J., McEvoy, L. K., Panizzon, M. S., Reas, E. T., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab475 · Cited by 25
Buhl, E., Kim, Y. A., Parsons, T., Zhu, B., Santa‐María, I., Lefort, R., & Hodge, J. J. L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105752 · Cited by 29
“…complex dysregulation may contribute to AD pathology, it will be interesting to study the role of Eph/ephrin signalling in inflammation in flies since EphA1 is implicated in regulating neuroinflammation, a common pathological feature of AD (Ransohoff, 2016; Villegas-Llerena et al., 2016).”
InfluentialKim, J., Jeong, Y., Lee, E. J., Park, J., Seo, H., & Kim, H.-S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.129 · Cited by 26
“However, exaggerated microglial activation is closely related with the occurrence and progression of various neurodegenerative diseases and neuropsychiatric disorders [3].”
BackgroundUpadhya, D., de Castro, O. W., Upadhya, R., & Shetty, A. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0898-y · Cited by 26
Toward a New Concept of Alzheimer’s Disease Models: A Perspective from Neuroinflammation
Gutiérrez, A., & Vitórica, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179914 · Cited by 24
Adhikari‐Devkota, A., Kurauchi, Y., Yamada, T., Katsuki, H., Watanabe, T., & Devkota, H. P. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12813 · Cited by 31
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 27
“The last decades have witnessed a progressive recognition of neuroinflammation as a possible important player in neurodegeneration [178].”
BackgroundPeripheral Routes to Neurodegeneration: Passing Through the Blood–Brain Barrier
Giannoni, P., Claeysen, S., Noè, F. M., & Marchi, N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00003 · Cited by 27
“…immune dialog where endothelium activation or permeability, perivascular immune cell homing, and brain entry of immune soluble factors prompt and sustain neuroglia inflammation [Figure 1; see Engelhardt et al. (2017) and Ransohoff (2016) for fundamental aspects of endothelial–leukocyte adhesion].”
BackgroundClarke, J.-P. W. E., Thibault, P. A., Salapa, H. E., Kim, D. E., Hutchinson, C., & Levin, M. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062909 · Cited by 30
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
“The neuroinflammatory response is mediated by resident immune cells (microglia and astrocytes), which release cytokines and chemokines (4, 77).”
BackgroundA New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
Kopp, K. O., Greer, M. E., Glotfelty, E. J., Hsueh, S., Tweedie, D., Kim, D. S., Reale, M., Vargesson, N., & Greig, N. H. (2023) · Biomolecules · doi:10.3390/biom13050747 · Cited by 26
“As the disease progresses, consequences of neuroinflammation, such as synaptic loss, are associated with the progressive loss of established central nervous system (CNS) functions, including mobility, coordination, memory, and learning [15].”
CD28null T cells in aging and diseases: From biology to assessment and intervention
Guan, Y., Cao, M., Wu, X., Yan, J., Hao, Y., & Zhang, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111807 · Cited by 28
A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer’s disease in 3xTg mice
Feng, X., Hou, Y., Liu, J., Yan, F., Dai, M., Chen, M., Wang, J., Li, J., Liu, Z., Sun, D., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00942-9 · Cited by 32
The role of parvalbumin interneuron dysfunction across neurodegenerative dementias
Smeralda, C. L., Pandit, S., Turrini, S., Reilly, J., Palmisano, A., Sprugnoli, G., Hampel, H. J., Benussi, A., Borroni, B., Press, D. Z., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102509 · Cited by 27
Zhu, W., Hu, Y., Shi, Y., Bao, H., Cheng, X., Jiang, M., Peng, Z., Song, J., Fang, F., Jian, C., et al. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128077 · Cited by 29
Lin, L., Ling, X., Chen, T., Zhou, Q., Huang, J., Huang, L., Lin, X., & Lin, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s503784 · Cited by 27
“5 This causes neural anatomical changes, alterations in the redox environment and low-grade chronic inflammation lead to neurodegenerative lesions, which in turn trigger pathological manifestations of neuronal and synaptic dysfunction related to cognitive function.”
Hassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 33
“Elevated NSE reflects neuronal damage and overwhelmed microglial clearance; enhancing response to NSE could mitigate inflammation [136].”
The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
Sim, K.-Y., Im, K. C., & Park, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155295 · Cited by 25
“Therefore, many studies have examined the contributions of adaptive immune systems to neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), which are related to neuroinflammation [20].”
BackgroundInfluentialAnticoagulants for Treatment of Alzheimer’s Disease
Grossmann, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200610 · Cited by 29
Long-Term Cognitive Deficits After Traumatic Brain Injury Associated With Microglia Activation
Saba, E. S., Karout, M., Nasrallah, L., Kobeissy, F. H., Darwish, H., & Khoury, S. J. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108815 · Cited by 29
Assmann, C. E., Weis, G. C. C., da Rosa, J. R., Bonadiman, B. D. S. R., Alves, A. D. O., Schetinger, M. R. C., Ribeiro, E. E., Morsch, V. M., & da Cruz, I. B. M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105085 · Cited by 30
How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders
Salucci, S., Stella, A. B., Battistelli, M., Burattini, S., Bavelloni, A., Cocco, L., Gobbi, P., & Faenza, I. (2021) · Biomolecules · doi:10.3390/biom11081109 · Cited by 28
“Thus, abnormal glial and astrocyte activation, as well as peripheral immune cell infiltration in the brain, is neurotoxic and seems to contribute to ALS and SMA pathology [41,42].”
Backgroundvan Ton, A. M. P., Leijsen, E. M. C. M.-V., Bergkamp, M. I., Bronkhorst, E. M., Pickkers, P., de Leeuw, F., Tuladhar, A. M., & Abdo, W. F. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005313 · Cited by 27
“Number of participants, n (%), without any infectious event during FU: 108 (33) 116 (35) 61 (18)”
BackgroundDuarte, P., Michalska, P., Crisman, E., Cuadrado, A., & Leon, R. M. (2022) · Antioxidants · doi:10.3390/antiox11020247 · Cited by 24
“Neuroinflammation has been demonstrated to be an essential contributor to PD pathogenesis, being a prominent feature of the disease [79,80].”
BackgroundVicente-Acosta, A., Giménez-Cassina, A., Díaz‐Nido, J., & Loría, F. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02442-w · Cited by 21
Zhao, Z., Guo, W., Xu, C., Wang, Q., Mao, C., & Wan, M. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139089 · Cited by 25
Tiwari, V., Singh, J., Tiwari, P., Chaturvedi, S., Gupta, S., Mishra, A., Singh, S., Wahajuddin, M., Hanif, K., & Shukla, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175623 · Cited by 26
Mendonca, P., Taka, E., Bauer, D., Cobourne-Duval, M. K., & Soliman, K. F. A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.011 · Cited by 24
“It has been several decades since the proposal that neuroinflammationmight promote the progression of neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's diseases (PD) (Glass et al., 2010; Ransohoff, 2016).”
BackgroundShao, Q.-H., Zhang, X., Chen, Y., Zhu, C., Shi, J., Yuan, Y., & Chen, N. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.04.014 · Cited by 26
IGF1 Gene Therapy Modifies Microglia in the Striatum of Senile Rats
Lockhart, E. F., Dolcetti, F. J. C., García‐Segura, L. M., Hereñú, C. B., & Bellini, M. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00048 · Cited by 24
“…to increased basal CNS neuroinflammation with aging and may represent a risk factor for cognitive and motor impairment, depression or diverse age related neurodegenerative diseases (Streit and Xue, 2010; Cunningham, 2013; Patel et al., 2015; Pekny and Pekna, 2016; Ransohoff, 2016; Spittau, 2017).”
BackgroundMoreno‐Martínez, L., de la Torre, M., Toivonen, J. M., Zaragoza, P., García‐Redondo, A., Calvo, A. C., & Osta, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00801 · Cited by 27
Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF
Deng, C., Zhu, J., Yuan, J., Xiang, Y., & Dai, L. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02910-5 · Cited by 25
Lietzau, G., Magni, G., Kehr, J., Yoshitake, T., Candeias, E., Duarte, A. I., Pettersson, H., Skogsberg, J., Abbracchio, M. P., Klein, T., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.004 · Cited by 28
Kurki, S., Srinivasan, R., Laine, J., Virtanen, M. A., Ala‐Kurikka, T., Voipio, J., & Kaila, K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113379 · Cited by 29
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 27
Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates
Ling, H., Gelpí, E., Davey, K., Jaunmuktane, Z., Mok, K. Y., Jabbari, E., Simone, R., R’Bibo, L., Brandner, S., Ellis, M. J., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02119-4 · Cited by 26
Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
Li, C., Chen, T., Chiu, M., Yen, R., Shih, M., & Lin, C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646440 · Cited by 25
“In addition, recent evidence has shown that neuroinflammation is critical to the pathogenesis of neurodegenerative disorders, including tauopathy (Ransohoff, 2016; Laurent et al., 2018).”
BackgroundEssex, A. L., Huot, J. R., Deosthale, P. J., Wagner, A., Figueras, J. H., Davis, A., Damrath, J. G., Pin, F., Wallace, J. M., Bonetto, A., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4572 · Cited by 26
“Additionally, TREM2 has been shown to contribute to the neuroinflammation that occurs during AD by altering microglial function.((20-22))”
BackgroundRezig, L., Chemkhi, H., Gharsallah, K., Mokbli, S., B’chir, F., Achour, N. B., Bourgou, S., & Chouaibi, M. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103958 · Cited by 24
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?
Engelender, S., Stefanis, L., Oddo, S., & Bellucci, A. (2022) · Movement Disorders · doi:10.1002/mds.29058 · Cited by 23
“In this scenario, even if pathological protein accumulation per se may not be sufficient to trigger neurodegeneration, it may contribute to neuronal injury and inflammatory cell activation, exacerbating neuronal loss.(67) Despite the multitude of open issues concerning the link between protein aggregation and neurodeg…”
BackgroundSelective GSK3β Inhibition Mediates an Nrf2-Independent Anti-inflammatory Microglial Response
Yousef, M. H., Salama, M., El‐Fawal, H. A. N., & Abdelnaser, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02923-2 · Cited by 24
Grossmann, K. (2022) · Biomedicines · doi:10.3390/biomedicines10081890 · Cited by 26
“Drug research also focuses on other key players in AD pathogenesis, which include inflammatory processes, associated with glial activity, the production of reactive oxygen species (ROS) and of hydrogen sulfide, vascular and BBB dysfunction, and decline in synapses and neurons [30,35,49].”
BackgroundSharma, P. K., Kishore, A., De, I., Negi, S., Kumar, G., Bhardwaj, S., & Singh, M. P. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105604 · Cited by 24
Zhang, X., Chen, X., Zhang, L., Sun, Y., Liang, Y., Li, H., & Zhang, Y. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105639 · Cited by 23
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 28
“…neuroin-flammation with the presentation of a variety of neuropsychiatric and neurodegenerative diseases as well as impaired cognitive function following concussions or traumatic brain injury (Heneka et al., 2015; Lyman et al., 2014; Najjar & Pearlman, 2015; Ransohoff, 2016; Troubat et al., 2021).”
Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers
Huang, L., Huang, Q., Xie, F., & Guo, Q. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.062 · Cited by 28
Lü, L., Li, X., Xu, P., Zheng, Y., & Wang, X. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.001 · Cited by 23
“Activated microglia can mediate neurodegeneration by producing a variety of cytotoxic factors, such as nitric oxide (NO), matrix metalloproteinases (MMPs) and cytokines [4].”
InfluentialCarroll, J. A., Race, B., Phillips, K. L., Striebel, J. F., & Chesebro, B. W. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000876 · Cited by 26
Infiltrating macrophages contribute to age-related neuroinflammation in C57/BL6 mice
Wolfe, H. E., Minogue, A. M., Rooney, S., & Lynch, M. A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.05.003 · Cited by 27
Libner, C. D., Salapa, H. E., & Levin, M. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134571 · Cited by 24
“Neuroinflammatory environments, including those within MS, have been shown to contribute to neurodegeneration, leading to further exacerbation of neuroinflammation [41] and resulting in an ongoing cycle of CNS damage.”
BackgroundGiansante, G., Marte, A., Romei, A., Prestigio, C., Onofri, F., Benfenati, F., Baldelli, P., & Valente, P. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2981-19.2020 · Cited by 27
“Inflammation influences pathogenesis and progression of most neurologic disorders, including those diseases for which the primary etiology is not inflammatory, such as Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis, or epilepsy (Ransohoff, 2016; Vezzani et al., 2019).”
BackgroundLian, H., Wang, B., Lu, Q., Chen, B., & Yang, H. M. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01084-1 · Cited by 23
“2003; Ransohoff 2016; Cui et al.”
Tian, Y., Milic, J., Monasor, L. S., Chakraborty, R., Wang, S., Yuan, Y., Asare, Y., Behrends, C., Tahirović, S., & Bernhagen, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04911-8 · Cited by 23
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action
Wilhelmsen, K., Deshpande, A., Tronnes, S. U., Mahanta, M., BANICKI, M., COCHRAN, M., Cowdin, S., Fortney, K., Hartman, G. D., Hughes, R. E., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242403 · Cited by 23
“Inflammation is associated with many age-related diseases, including neurodegenerative conditions, cancer, and metabolic and cardiovascular diseases (Franceschi et al., 2018; Ransohoff, 2016).”
Neuroimmune dynamics and brain aging: mechanisms and consequences
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1715045 · Cited by 24
“With aging, this delicate balance tends toward dysregulation, and contributes both to regulative functional decline and heightened vulnerability to neurodegenerative diseases (Ransohoff, 2016; Di Benedetto et al., 2017).”
Johnson, S. L., Iannucci, J., Seeram, N. P., & Grammas, P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.068 · Cited by 23
Chang, L., Liang, H., Kandel, S. R., & He, J. J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09963-2 · Cited by 23
“Increased expressions of pro-inflammatory cytokines are major hallmarks of neuroinflammation (Ransohoff 2016; Gilhus and Deuschl 2019).”
BackgroundCross-talk between α-synuclein and the microtubule cytoskeleton in neurodegeneration
Mazzetti, S., Calogero, A. M., Pezzoli, G., & Cappelletti, G. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114251 · Cited by 24
“Collectively, these alterations lead to overall inflammation that involves glial cells (Hirsch and Hunot, 2009; Mazzetti et al., 2022; Ransohoff, 2016).”
BackgroundMicroglia: Friends or Foes in Glaucoma? A Developmental Perspective
Ahmad, I., & Subramani, M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac077 · Cited by 23
Zhu, H., Wu, E., Pan, Z., Zhang, C., Zhang, Y., Liao, Q., Wang, Y., Sun, Y., Ye, M., & Wu, W. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04084 · Cited by 22
Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila
Yan, L., Zhou, J., Yuan, L., Ye, J., Zhao, X., Ren, G., & Chen, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1246960 · Cited by 23
“IBDs are characterized by relapsing mucosal in fl ammation causing severe intestinal epithelial injury and subsequent intestinal barrier dysfunction (Atreya and Neurath, 2015).”
InfluentialLicochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
Olloquequi, J., Ettcheto, M., Cano, A. C., Fortuna, A. C., Bicker, J., Sánchez‐López, E., Paz, C., Ureña, J. M., Verdaguer, E., Auladell, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814177 · Cited by 26
“In any case, whether by promoting peripheral activation of the immune system or exerting an anti-inflammatory action on microglia, Lico-A represents a potential therapy against AD and cognitive loss [117,118].”
Ricciardelli, A., Robledo, A., Fish, J. E., Kan, P. T. M., Harris, T. H., & Wythe, J. D. (2023) · Biomedicines · doi:10.3390/biomedicines11112876 · Cited by 24
Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia
Haraguchi, Y., Mizoguchi, Y., Ohgidani, M., Imamura, Y., Murakawa‐Hirachi, T., Nabeta, H., Tateishi, H., Kato, T. A., & Monji, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1033-0 · Cited by 25
“linear causality as proposed in the original amyloid hypothesis [12].”
BackgroundBittlinger, M., & Müller, S. (2018) · BMC Medical Ethics · doi:10.1186/s12910-018-0275-4 · Cited by 26
“And it also differs from innovative routes like the neuroinflammation hypothesis of AD [81].”
BackgroundJiang, C., Zou, X., Zhu, R., Shi, Y.-M., Wu, Z., Zhao, F., & Chen, L. (2018) · Journal of neurosurgery · doi:10.3171/2018.1.jns172938 · Cited by 24
Prado, L. D. G. R., Rocha, N. P., de Souza, L. C., Bicalho, I. C. S., Gómez, R. S., Vidigal-Lopes, M., Braz, N. F. T., Vieira, É. L. M., & Teixeira, A. L. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.033 · Cited by 26
Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
Bossù, P., Salani, F., Ciaramella, A., Sacchinelli, E., Mosca, A., Banaj, N., Assogna, F., Orfei, M. D., Caltagirone, C., Gianni, W., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00285 · Cited by 25
“, 2000) and, more recently, a skewed immune response both in brain and periphery has been blamed for a defective Aβ clearance leading to AD development (Heneka et al., 2015; Marsh et al., 2016; Ransohoff, 2016).”
BackgroundGiacco, V., Panattoni, G., Medelin, M., Bonechi, E., Aldinucci, A., Ballerini, C., & Ballerini, L. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1519-z · Cited by 26
Grimsey, N. L., Savinainen, J. R., Attili, B. N. N. R., & Ahamed, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.004 · Cited by 22
Impaired Innate Immunity Mechanisms in the Brain of Alzheimer’s Disease
Romagnoli, M., Porcellini, E., Carbone, I., Veerhuis, R., & Licastro, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031126 · Cited by 22
“The efficiency of immune responses declines with advancing age [24,25], and old age is a major risk factor for AD.”
BackgroundLi, C., Yang, W., Wei, Q., & Shang, H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02053-7 · Cited by 23
Bernardo, J., Malheiro, I., Videira, R. A., Valentão, P., Paiva‐Santos, A. C., Veiga, F., & Andrade, P. B. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113865 · Cited by 27
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS
Rose, F. D., Marotta, R., Talani, G., Catelani, T., Solari, P., Poddighe, S., Borghero, G., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2017) · Scientific Reports · doi:10.1038/srep41059 · Cited by 23
A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis
Manna, I., Benedittis, S. D., & Porro, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168921 · Cited by 26
“The ability to identify the neurotoxic and pro-inflammatory mechanisms causing neuronal vulnerability in MS progression made the study of glial cell populations particularly interesting [49].”
BackgroundGut Microbiota and Mental Health: A Comprehensive Review of Gut-Brain Interactions in Mood Disorders
Mehta, I., Juneja, K., Nimmakayala, T., Bansal, L. R., Pulekar, S., Duggineni, D., Ghori, H. K., Modi, N. M., & Younas, S. (2025) · Cureus · doi:10.7759/cureus.81447 · Cited by 56
Metabolomics in Parkinson's disease
Troisi, J., Landolfi, A., Cavallo, P., Marciano, F., Barone, P., & Amboni, M. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.003 · Cited by 25
The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
Golzari-Sorkheh, M., Brown, C. E., Weaver, D. F., & Reed, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210660 · Cited by 23
Jonavičė, U., Romenskaja-Avgul, D., Kriaučiūnaitė, K., Jarmalavičiūtė, A., Pajarskienė, J., Kašėta, V., Tunaitis, V., Malm, T., Giniatullin, R. A., & Pivoriūnas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010970 · Cited by 20
“Dysregulated microglial response is important for the development and propagation of various neurological disorders, and therefore the targeting of neuroinflammatory microglia has been considered a promising therapeutic approach [2,3].”
BackgroundAnselmi, C., Kowarsky, M., Gasparini, F., Caicci, F., Ishizuka, K. J., Palmeri, K. J., Raveh, T., Sinha, R., Neff, N. F., Quake, S. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203032119 · Cited by 26
Roles of Siglecs in neurodegenerative diseases
Siew, J. J., Chern, Y., Khoo, K., & Angata, T. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101141 · Cited by 23
Schindler, L. S., Subramaniapillai, S., Barth, C., van der Meer, D., Pedersen, M. L., Kaufmann, T., Maximov, I. I., Linge, J., Leinhard, O. D., Beck, D., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103239 · Cited by 32
“…tissue levels (Aguilar-Valles et al., 2015; Miller and Spencer, 2014), even specifically during the menopause transition (Lee et al., 2009), as well as decreasing oestrogens (McCarthy and Raval, 2020), brain atrophy (Luo et al., 2022), and dementia risk (Heneka et al., 2015; Ransohoff, 2016).”
Zhang, C., Xue, Z. H., Zhu, L., Zhou, J., Zhuo, L., Zhang, J., Zhang, X., Liu, W., Han, L., & Liao, W. (2023) · Food & Function · doi:10.1039/d2fo02939a · Cited by 21
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.